03 August, 2026 | Monday | Expert Insight

As biologics, biosimilars, and advanced cell and gene therapies continue to reshape the Asia-Pacific biopharmaceutical landscape, manufacturers are under increasing pressure to enhance cold ch...

05 August, 2026 | Wednesday | Analysis

How this list was built Ten bottlenecks were identified from facility interviews, technical sessions at regional bioprocessing conferences and published case studies. Each entry pairs a constraint with...

04 August, 2026 | Tuesday | Interaction

BioPharma APAC speaks with Girisan Kariangal, Regional Vice President – Business Development & Alliance Management, Menarini Asia-Pacific, on the evolving opportunities and challenges of expanding acr...

07 August, 2026 | Friday | News

Porton Advanced Solutions Ltd. ("Porton Advanced") has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton...

10 August, 2026 | Monday | Opinion

Asia Pacific’s ageing economies are entering a more demanding phase of healthcare planning. As populations live longer, the challenge for healthcare systems is no longer only about extending life expectan...

10 August, 2026 | Monday | News

Cardiologists from China and Indonesia have successfully completed Southeast Asia's first complex Chronic Total Occlusion (CTO) procedure guided by United Imaging's uAngio AVIVA angiography system. The procedu...

10 August, 2026 | Monday | News

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the worl...